HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G Ralph Corey Selected Research

oritavancin

1/2018Single Intravenous Dose of Oritavancin for Treatment of Acute Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: Summary of Safety Analysis from the Phase 3 SOLO Studies.
1/2017Efficacy and Safety of Oritavancin Relative to Vancomycin for Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in the Outpatient Setting: Results From the SOLO Clinical Trials.
11/2016Pooled analysis of single-dose oritavancin in the treatment of acute bacterial skin and skin-structure infections caused by Gram-positive pathogens, including a large patient subset with methicillin-resistant Staphylococcus aureus.
12/2015Prolonged Use of Oritavancin for Vancomycin-Resistant Enterococcus faecium Prosthetic Valve Endocarditis.
5/2015Oritavancin for acute bacterial skin and skin structure infections.
1/2015Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study.
6/2014Single-dose oritavancin in the treatment of acute bacterial skin infections.
1/2014Dalbavancin or oritavancin for skin infections.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


G Ralph Corey Research Topics

Disease

70Infections
01/2021 - 01/2002
22Bacteremia
01/2018 - 07/2003
21Endocarditis
01/2020 - 01/2004
11Sepsis (Septicemia)
01/2020 - 08/2005
9Healthcare-Associated Pneumonia
08/2017 - 01/2011
6Abscess
01/2018 - 08/2005
6Nausea
02/2015 - 06/2008
5Cellulitis
01/2018 - 11/2007
4Wound Infection (Wound Infections)
04/2020 - 06/2011
4Body Weight (Weight, Body)
01/2018 - 08/2006
4Staphylococcal Infections
04/2013 - 01/2002
4Pruritus (Itching)
11/2012 - 06/2008
4Heart Failure
03/2010 - 08/2005
3Pneumonia (Pneumonitis)
01/2018 - 08/2012
3Fever (Fevers)
01/2017 - 06/2014
3Chronic Kidney Failure (Chronic Renal Failure)
05/2006 - 02/2005
2Hypersensitivity (Allergy)
01/2020 - 01/2007
2Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
06/2019 - 01/2014
2Acute Kidney Injury (Acute Renal Failure)
11/2018 - 04/2014
2Septic Shock (Toxic Shock Syndrome)
11/2018 - 07/2013
2Surgical Wound
06/2017 - 01/2016
2Wounds and Injuries (Trauma)
06/2017 - 01/2016
2Bacterial Pneumonia
09/2015 - 03/2015
2Communicable Diseases (Infectious Diseases)
01/2014 - 01/2009
2Soft Tissue Infections
09/2011 - 06/2005
2Headache (Headaches)
11/2010 - 11/2010
2Mediastinitis
08/2005 - 07/2003
1Fatigue
04/2020
1Diarrhea
04/2020
1Hyperkalemia
11/2018
1Coinfection
09/2015
1Osteomyelitis
05/2015
1Thrombocytopenia (Thrombopenia)
01/2015
1Erysipelas
08/2014
1Injection Site Reaction
04/2013
1Mycoses (Diseases, Fungus)
03/2012
1Histoplasmosis
03/2012
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
09/2011
1Stroke (Strokes)
03/2010
1Eosinophilia
08/2009
1Strongyloidiasis
08/2009
1Neoplasms (Cancer)
05/2009

Drug/Important Bio-Agent (IBA)

35VancomycinFDA LinkGeneric
04/2020 - 06/2005
23Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 08/2006
16telavancinFDA Link
03/2017 - 06/2005
9iclaprim (AR 100)IBA
04/2020 - 08/2017
8oritavancinIBA
01/2018 - 01/2014
8DaptomycinFDA Link
03/2017 - 08/2006
7CeftarolineFDA Link
06/2019 - 02/2009
7Methicillin (Metin)FDA Link
09/2011 - 02/2005
6Pharmaceutical PreparationsIBA
01/2019 - 12/2007
6CoagulaseIBA
01/2018 - 11/2004
6Linezolid (Zyvox)FDA Link
12/2015 - 10/2009
4Gentamicins (Gentamicin)FDA LinkGeneric
01/2016 - 08/2006
4tedizolidIBA
02/2015 - 04/2012
4IceIBA
09/2013 - 01/2004
4Penicillins (Penicillin)FDA Link
03/2009 - 06/2005
3Panton-Valentine leukocidinIBA
11/2018 - 09/2008
3AztreonamFDA LinkGeneric
11/2010 - 09/2010
2eravacyclineIBA
01/2020 - 01/2020
2ExotoxinsIBA
11/2018 - 12/2009
2Tigecycline (Tygacil)FDA Link
12/2015 - 10/2009
2CreatinineIBA
09/2015 - 06/2008
2Oxazolidinones (2 Oxazolidone)IBA
02/2015 - 01/2015
2Cefazolin (Ancef)FDA LinkGeneric
08/2009 - 01/2007
2Proteins (Proteins, Gene)FDA Link
08/2006 - 09/2004
1exebacaseIBA
01/2020
1delafloxacinIBA
01/2019
1Trimethoprim (Proloprim)FDA LinkGeneric
11/2018
1SulfonamidesIBA
11/2018
1Hemolysin Proteins (Hemolysins)IBA
11/2018
1Saline SolutionIBA
06/2017
1dalbavancinIBA
01/2014
1RNA (Ribonucleic Acid)IBA
01/2014
1ProteomeIBA
07/2013
1VaccinesIBA
04/2013
1V710 vaccineIBA
04/2013
1cefilavancinIBA
11/2012
1LipoglycopeptidesIBA
12/2011
1Enterotoxins (Enterotoxin)IBA
09/2011
1Fusidic Acid (Fucithalmic)IBA
06/2011
1Clindamycin (Cleocin)FDA LinkGeneric
05/2011
1Amoxicillin (Wymox)FDA LinkGeneric
05/2011
1Albendazole (Albenza)FDA Link
08/2009
1Cephalosporins (Cephalosporin Antibiotics)IBA
08/2009
1Therapeutic UsesIBA
05/2009
1Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric
05/2009

Therapy/Procedure

28Therapeutics
01/2020 - 09/2004
11Renal Dialysis (Hemodialysis)
08/2009 - 01/2002
6Catheters
02/2008 - 03/2005
3Length of Stay
11/2015 - 02/2005
2Defibrillators (Defibrillator)
10/2020 - 05/2009
2Prostheses and Implants (Prosthesis)
12/2005 - 03/2005
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
08/2005 - 07/2003
1Cardiac Resynchronization Therapy
10/2020
1Duration of Therapy
01/2018
1Mechanical Ventilators (Ventilator)
09/2015
1Highly Active Antiretroviral Therapy (HAART)
03/2012
1Antibiotic Prophylaxis
05/2011
1Heart-Assist Devices
04/2011